Eutropin 4IU Injection contains Somatropin, a recombinant human growth hormone used to treat growth hormone deficiencies in children and adults. Each 4IU dose delivers a precise amount of Somatropin to stimulate growth, cell reproduction, and regeneration. It is primarily prescribed for pediatric patients with growth failure due to inadequate endogenous growth hormone secretion, Turner syndrome, chronic kidney disease, or idiopathic short stature. In adults, Eutropin may be used to address growth hormone deficiency resulting from pituitary disease, surgery, radiation, or trauma, improving body composition, bone density, and exercise capacity. The injection is administered subcutaneously, typically once daily, with dosage and duration tailored to individual patient needs and monitored by healthcare professionals. Eutropin 4IU Injection promotes protein synthesis, increases muscle mass, reduces fat accumulation, and supports overall metabolic function. Patients should follow prescribed guidelines strictly to minimize potential side effects such as injection site reactions, joint pain, edema, or glucose intolerance. Regular monitoring of growth parameters, glucose levels, and thyroid function is recommended during treatment. Eutropin should be stored as per manufacturer instructions and kept out of reach of children. It is essential to consult a healthcare provider before initiating therapy to ensure safe and effective use.